Loading Programs

Available Programs

Programs Search and Views Navigation

June 2021

  • ONLINE ON-DEMAND

The Role of Telehealth in Pediatric and Adult Infections: Best Practices and Care Considerations for Influenza

June 18, 2021 - June 18, 2022

Are you prepared to manage influenza in the era of COVID-19? Listen to Dr Paul G. Auwaerter’s and Dr Javeed Siddiqui’s discussion on the challenges of influenza management in the midst of the COVID-19 pandemic. Explore solutions to your questions about best practices to assess influenza via telehealth, strategies for influenza prophylaxis, and selecting antivirals for children, adolescents, and adults, including patients at high risk of influenza complications. Click here to enter this activity: https://learning.freecme.com/a/37397P2C6ABt

Find out more »

July 2021

  • ONLINE ON-DEMAND

The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

July 16, 2021 - July 16, 2022

In this educational activity, faculty members Nina Delaney Wagner-Johnston, MD, and Seema A. Bhat, MD, review current efficacy and safety data for targeted therapies approved for patients with treatment-naïve or relapsed/refractory (R/R) CLL, as well as emerging strategies for treatment. They evaluate clinical trial data, along with patient- and disease-related factors, that allow for the individualization of therapy selection and sequencing of therapy in first and second lines of therapy and beyond. https://reachmd.com/programs/cme/evolving-landscape-chronic-lymphocytic-leukemia-selecting-and-managing-targeted-therapy/12643/ 

Find out more »

August 2021

  • ONLINE ON-DEMAND

Strategies for PD-L1 Testing and Targeted Therapy With Immune Checkpoint Inhibitors for NSCLC

August 17, 2021 @ 12:00 am - August 17, 2022 @ 11:59 pm EDT

Join Dr Hossein Borghaei and Dr Kurt Schalper in this personalized adaptive learning platform as they share insights into the role of PD-L1 testing to determine the best approach to ICI therapy, current efficacy and safety data for ICI therapies in NSCLC, and how to identify and mitigate immune-related adverse events (irAEs).   Click below to enter this activity: https://spirelearning.realcme.com/learner/course/2828

Find out more »
  • ONLINE ON-DEMAND

More Targets, More Targeted Therapies: Evolving Concepts and Therapies for Atopic Dermatitis

August 25, 2021 - August 25, 2022

Are you prepared to accurately assess the severity of atopic dermatitis (AD) across a diverse spectrum of age, comorbidities, and skin of color? Are you aware of the new and emerging targeted therapy options for mild to severe AD and the evolving physiological concepts behind their rationale? The goals of this activity are to educate pediatric and adult dermatologists, allergists, and dermatologic advanced practice providers (APPs) on the diagnosis and assessment of AD and its severity in children, adolescents, and…

Find out more »

October 2021

  • ONLINE ON-DEMAND

A New Era in Managing Alzheimer’s Disease: Highlights From AAIC 2021

October 18, 2021 - October 18, 2022

Did you miss the Alzheimer’s Association International Conference (AAIC) 2021 Annual Virtual Scientific Meeting? Key advances in the diagnosis and treatment of Alzheimer’s disease (AD) were presented at the AAIC 2021 meeting, including several reports on novel biomarkers for identifying early signs of AD and late-breaking clinical data on approved and emerging treatment strategies. Join Dr Zoe Arvanitakis and Dr Marwan Sabbagh as they share important take-home messages from select abstracts presented at the AAIC 2021 meeting, and access our resource library stocked…

Find out more »

December 2021

  • ONLINE ON-DEMAND

Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – A Caucasian Adult Female With Recurrent, Uncontrolled Angioedema and Urticaria

December 16, 2021 @ 12:00 am - December 16, 2022 @ 11:59 pm EST

Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the diagnosis, management, and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient receiving suboptimal care and challenge your clinical decision-making skills. https://realcme.realcme.com/learner/course/2854

Find out more »
  • ONLINE ON-DEMAND

Itching for a CSU Cure: The Shift From Symptom Relief to Curative Therapies – An Older African American Adult Male With Widespread, Persistent Pruritus

December 16, 2021 @ 12:00 am - December 16, 2022 @ 11:59 pm EST

Join Chesahna Kindred, MD, MBA, FAAD, and Jonathan A. Bernstein, MD, as they discuss missed opportunities for the management and assessment of chronic spontaneous urticaria (CSU) in this interactive learning experience that uniquely mirrors what you may encounter in clinical practice. The activity will present you with a CSU patient with skin of color and challenge your clinical decision-making skills. https://realcme.realcme.com/learner/course/2855    

Find out more »
  • ONLINE ON-DEMAND

Key Developments in Alzheimer’s Disease: Expert Insights on CTAD and ANA 2021 Annual Meetings

December 22, 2021 - December 22, 2022

Looking for an expert-guided roundup of the 14th Clinical Trials on Alzheimer’s Disease (CTAD) and the American Neurological Association (ANA) annual meetings? Dr. Zoe Arvanitakis and Dr. Marwan Sabbagh offer their insights on key findings in the assessment and management of patients with Alzheimer’s disease (AD). Dive into this highly interactive educational activity and access our resource library stocked with video summaries and peer-reviewed articles to get up-to-date on recent advances in novel biomarkers for identifying early signs of AD and…

Find out more »

January 2022

  • ONLINE ON-DEMAND

Optimizing Outcomes in Newly Diagnosed Multiple Myeloma: Integrating Anti-CD38 Monoclonal Antibody Therapy Into Clinical Practice

January 14, 2022 @ 12:00 am - January 14, 2023 @ 11:59 pm EST

Did you miss the latest updates on multiple myeloma presented at ASH 2021? Join Dr Faith Davies and Dr Nina Shah as they review late-breaking data on approved and emerging therapies for newly diagnosed multiple myeloma! https://learning.freecme.com/a/38663PA6uG2J  

Find out more »
  • ONLINE ON-DEMAND

Seeing Beyond the Symptoms: Early Diagnosis and Treatment of Dry Eye and Meibomian Gland Dysfunction

January 21, 2022 - January 21, 2023

Dry eye disease is one of the most common ophthalmic complaints; it results from the activity of various pathways and is considered a multifactorial disease. An important factor that contributes to the onset of dry eye disease is meibomian gland dysfunction. Meibomian gland dysfunction causes a disruption in the tear film lipid layer, which affects the rate of tear evaporation. This evaporation leads to tear hyperosmolarity, eventually triggering the onset of dry eye disease. Dry eye disease and meibomian gland…

Find out more »
  • ONLINE ON-DEMAND

Not Just Controlling the Itch: Recent Developments in Treating Prurigo Nodularis – A Caucasian Adult Male With History of Uncontrolled PN and Associated Comorbidities

January 25, 2022 - January 25, 2023

Join our expert faculty, Chesahna Kindred, MD, MBA, FAAD and Shawn Kwatra, MD, FAAD, as they discuss patient scenarios utilizing methods to avoid missed opportunities for the care team, assess the clinical efficacy and safety of standard off-label, as well as emerging therapies, and ultimately devise effective treatment plans that encourage long-term adherence and address residual disease burden for patients with PN.   Click the link below to access the course: https://realcme.realcme.com/learner/course/2866

Find out more »
  • ONLINE ON-DEMAND

Not Just Controlling the Itch: Recent Developments in Treating Prurigo Nodularis – An Older African American Female Adult Presenting With Nodular Lesions and Persistent Itching

January 25, 2022 - January 25, 2023

Join our expert faculty, Chesahna Kindred, MD, MBA, FAAD and Shawn Kwatra, MD, FAAD, as they discuss patient scenarios utilizing methods to avoid missed opportunities for the care team, assess the clinical efficacy and safety of standard off-label, as well as emerging therapies, and ultimately devise effective treatment plans that encourage long-term adherence and address residual disease burden for patients with PN.   Click the link below to access the course: https://realcme.realcme.com/learner/course/2865

Find out more »

February 2022

  • ONLINE ON-DEMAND

From Reversing DOACs to Restarting Anticoagulation: Know and Apply the Guidelines

February 18, 2022 - February 18, 2023

When and how to use specific direct oral anticoagulant (DOAC) reversal agents is not straightforward. Two major professional societies (eg, the American College of Cardiology and the American College of Emergency Physicians ) issued expert panel recommendations for anticoagulant reversal only within the last year. In addition, reports of real-world experience with prothrombin complex concentrates (PCCSs) for DOAC reversal have been published in the recent past, potentially prompted by familiarity with PCCSs to reverse warfarin among other factors. Furthermore, evaluating…

Find out more »

March 2022

  • ONLINE ON-DEMAND

Incorporating New Therapeutic Tools for Migraine Prevention: An Expert-Guided Discussion

March 18, 2022 - March 18, 2023

Looking for guidance on who may benefit from calcitonin gene-related peptide (CGRP)-targeted therapies for migraine prevention? Unsure which migraine preventive therapy may be best for your patient? In this CliniClip activity, Drs Jessica Ailani and Susan Hutchinson use real-world patient scenarios to share their expert insights on who may benefit from a CGRP-targeted therapy and highlight when a small molecule or a monoclonal antibody may be appropriate for migraine prevention.   Click the link below to access the course: https://cmepreview.healio.com/neurology/20220207/incorporating-new-therapeutic-tools-for-migraine-prevention-an-expert-guided-discussion/cme-overview…

Find out more »

June 2022

  • UPCOMING LIVE PROGRAMS

A Family Physician’s Guide for Early Detection of Cognitive Impairment and Alzheimer’s Disease: Moving Towards Earlier Recognition and Improved Management

June 18 @ 8:00 am - 9:00 am EDT
Hotel Effie Sandestin, 1 Grand Sandestin Blvd
Miramar Beach, FL United States
+ Google Map

What do family physicians need to know about caring for patients with Alzheimer’s disease (AD)? Family physicians are well positioned to spot the earliest signs of cognitive decline—and patients are more likely to discuss cognitive concerns with a clinician they know and trust. This session will provide you with the latest information regarding screening for AD-related dementia, diagnostic best practices, efficacy and safety data of recently approved and emerging therapeutic agents, and effective communication strategies. You will leave this 1-hour…

Find out more »
+ Export Events